InvestorsHub Logo
Followers 15
Posts 1647
Boards Moderated 0
Alias Born 05/15/2015

Re: None

Friday, 03/31/2017 1:22:49 PM

Friday, March 31, 2017 1:22:49 PM

Post# of 3833
GALT: Other NASH play BLRX @ .90s.

BioLineRX did a $25M secondary today that sent the stock to .90s.

The great move in GALT is a set-up for BLRX now that the secondary is out of the way and BLRX is flush.

Novartis is the BLRX partner on the NASH liver drug.

Link:
http://www.fiercebiotech.com/biotech/novartis-partner-biolinerx-licenses-nash-drug-after-joint-evaluation
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News